A comprehensive meta-analysis of transcriptome data to identify signature genes associated with pancreatic ductal adenocarcinoma

A comprehensive meta-analysis of transcriptome data to identify signature genes associated with pancreatic ductal adenocarcinoma

Show other versions (1)

Bibliographic Details
Main Authors:	Shirin Omidvar Kordshouli, Ahmad Tahmasebi, Ali Moghadam, Amin Ramezani, Ali Niazi
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2024-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10849254/?tool=EBI

Similar Items

A comprehensive meta-analysis of transcriptome data to identify signature genes associated with pancreatic ductal adenocarcinoma.
by: Shirin Omidvar Kordshouli, et al.
Published: (2024-01-01)

Heterogeneity of weight loss and transcriptomic signatures in pancreatic ductal adenocarcinoma
by: Andrea N. Riner, et al.
Published: (2024-02-01)

Integrated transcriptome meta-analysis of pancreatic ductal adenocarcinoma and matched adjacent pancreatic tissues
by: Sevcan Atay
Published: (2020-10-01)

Metabolic signatures in pancreatic ductal adenocarcinoma: diagnostic and therapeutic implications
by: Ruining Gong, et al.
Published: (2023-12-01)

Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma
by: Carlo Caputo, et al.
Published: (2024-02-01)

Identifying genes that are required for the maintenance of pancreatic ductal adenocarcinoma
by: Jenq, Harry
Published: (2013)

An Integrated Meta-Analysis of Secretome and Proteome Identify Potential Biomarkers of Pancreatic Ductal Adenocarcinoma
by: Grasieli de Oliveira, et al.
Published: (2020-03-01)

A Comprehensive Transcriptional Signature in Pancreatic Ductal Adenocarcinoma Reveals New Insights into the Immune and Desmoplastic Microenvironments
by: Irene Pérez-Díez, et al.
Published: (2023-05-01)

Novel prognostic gene signature for pancreatic ductal adenocarcinoma based on hypoxia
by: Min Ren, et al.
Published: (2023-08-01)

Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma.
by: Dung-Tsa Chen, et al.
Published: (2015-01-01)

Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma
by: Wayne Croft, et al.
Published: (2023-06-01)

THE SUBTYPES OF PANCREATIC DUCTAL ADENOCARCINOMAS
by: Apeksha Kakkar, et al.
Published: (2016-12-01)

Syndecans and Pancreatic Ductal Adenocarcinoma
by: Nausika Betriu, et al.
Published: (2021-02-01)

Immunophenotypes of pancreatic ductal adenocarcinoma: Meta‐analysis of transcriptional subtypes
by: De Santiago, I, et al.
Published: (2019)

A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma
by: Tiandong Li, et al.
Published: (2023-11-01)

The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma
by: Hao Lu, et al.
Published: (2022-09-01)

Pancreatic Ductal Adenocarcinoma Associated with Autoimmune Pancreatitis
by: Raffaele Pezzilli, et al.
Published: (2011-07-01)

Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma
by: Ujjwal Mukund Mahajan, et al.
Published: (2021-07-01)

Robust Validation and Comprehensive Analysis of a Novel Signature Derived from Crucial Metabolic Pathways of Pancreatic Ductal Adenocarcinoma
by: Wenchao Gu, et al.
Published: (2022-04-01)

The T-cell architecture of pancreatic ductal adenocarcinoma
by: Sivakumar, S, et al.
Published: (2019)

The T cell architecture of pancreatic ductal adenocarcinoma
by: Sivakumar, S, et al.
Published: (2019)

Ubiquitin signaling in pancreatic ductal adenocarcinoma
by: Shengnan Lv, et al.
Published: (2023-12-01)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
by: Kongyuan Wei, et al.
Published: (2021-04-01)

Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
by: Tarak Chouari, et al.
Published: (2023-08-01)

An Immunological Glance on Pancreatic Ductal Adenocarcinoma
by: Michael Karl Melzer, et al.
Published: (2020-05-01)

Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma
by: Vida Karimnia, et al.
Published: (2021-08-01)

Advances in Pancreatic Ductal Adenocarcinoma Treatment
by: Eric M. Anderson, et al.
Published: (2021-11-01)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
by: Sohei Satoi
Published: (2021-08-01)

Molecular imaging of pancreatic ductal adenocarcinoma
by: Wei Huang, et al.
Published: (2023-10-01)

Oral mycobiota and pancreatic ductal adenocarcinoma
by: Ailin Wei, et al.
Published: (2022-12-01)

Development of a MicroRNA Signature Predictive of Recurrence and Survival in Pancreatic Ductal Adenocarcinoma
by: Nikhil T. Sebastian, et al.
Published: (2021-10-01)

Identification of an unfolded protein response-related signature for predicting the prognosis of pancreatic ductal adenocarcinoma
by: Lishan Fang, et al.
Published: (2023-01-01)

Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA
by: Huanwen Wu, et al.
Published: (2022-11-01)

A Comprehensive Review of the Current and Future Role of the Microbiome in Pancreatic Ductal Adenocarcinoma
by: Nabeel Merali, et al.
Published: (2022-02-01)

Single Cell RNA-Seq Identifies Immune-Related Prognostic Model and Key Signature-SPP1 in Pancreatic Ductal Adenocarcinoma
by: Kai Chen, et al.
Published: (2022-09-01)

An immunogenic cell death-related gene expression signature in predicting prognosis of pancreatic ductal adenocarcinoma
by: Xiaobo Wang, et al.
Published: (2024-02-01)

The value of enhanced CT features and texture-signatures in assessing the inflammatory infiltration of pancreatic ductal adenocarcinoma
by: Fangqing Wang, et al.
Published: (2023-02-01)

Imaging p53 in pancreatic ductal adenocarcinoma
by: Koustoulidou, S
Published: (2017)

Inflammatory Cytokines and Radiotherapy in Pancreatic Ductal Adenocarcinoma
by: Sylvia S. W. Ng, et al.
Published: (2022-12-01)

Biomarker Panel for the Diagnosis of Pancreatic Ductal Adenocarcinoma
by: Hongbeom Kim, et al.
Published: (2020-06-01)